BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer

Autor: Fan, Fushun, Zhou, Minhua, Ye, Xiaolan, Mo, Zhenxian, Ma, Yaru, Luo, Liying, Liang, Xiaotong, Liu, Haiqi, Weng, Yunwo, Lin, Mingsheng, Liu, Xinjian, Cai, Xiong, Qian, Changgeng
Zdroj: In Translational Oncology February 2021 14(2)
Databáze: ScienceDirect